The Ethical Review Board of Sweden approved the study and all participants signed a written informed consent prior to inclusion (Dnr: 2019-05111 and 2020-05470). Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD)…
Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeksAmycretin demonstrated statistically significant reductions in HbA1c with up to 89.1% achieving HbA1c levels below 7%Amycretin appeared to…
Study design INTIMET was a single-site investigator-initiated phase 3 randomized placebo-controlled trial that was approved by the St Vincent’s Hospital Human Research and Ethics Committee (Sydney) and was conducted in…
A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works about as well as injectable semaglutide for people…
A breakthrough weight loss pill from the maker of Mounjaro helped patients shed weight and slash high blood sugar, promising data has shown. A late stage trial showed users could lose almost 10…
New real-world evidence from the Netherlands shows that oral semaglutide meaningfully improves blood sugar and body weight in routine diabetes care, confirming clinical trial benefits in everyday practice. Study: Real-world…
Study design and participants The STUDIA trial evaluated whether an advanced meal bolusing approach —a simulation-assisted decision support system (SA-DSS arm) would be superior in TIR to the current best…
Credit: Unsplash/CC0 Public Domain The Primary Oral Insulin Trial (POInT) investigates whether type 1 diabetes in at-risk children can be prevented through oral insulin treatment. First results mark an important…
NEW YORK, Nov. 6, 2025 /PRNewswire/ — Results of the Bayer-led Phase 3 FINE-ONE clinical trial, presented at the American Society of Nephrology Kidney Week in Houston, demonstrate that finerenone significantly…
ST. PAUL, Minn., Nov. 6 (UPI) — Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease…